Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a pr...

por Bala, Cornelia, Cerghizan, Anca, Mihai, Bogdan-Mircea, Moise, Mihaela, Guja, Cristian
Publicado 2022

Expert Opinion on the Therapeutic Use of the Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective

por Haluzík, Martin, Flekač, Milan, Lengyel, Csaba, Taybani, Zoltán, Guja, Cristian, Mihai, Bogdan-Mircea, Cerghizan, Anca, Martinka, Emil, Kovacs, Gabor, Kempler, Péter
Publicado 2020